ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Insights, Forecast to 2030
Published Date: December 2024
|
Report Code: QYRE-Auto-30L5761
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Epidermal Growth Factor Receptor EGFR Inhibitor Market Insights Forecast to 2028
BUY CHAPTERS

Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Insights, Forecast to 2030

Code: QYRE-Auto-30L5761
Report
December 2024
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Amgen Inc
Astrazeneca plc
Eli Lilly and Co
F Hoffmann La Roche Ltd
Novartis

Epidermal Growth Factor Receptor (EGFR) Inhibitor Market

The epidermal growth factor receptor (EGFR; ErbB-1; HER1 in humans) is a transmembrane protein that is a receptor for members of the epidermal growth factor family (EGF family) of extracellular protein ligands.
Market Analysis and Insights: Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market
The global Epidermal Growth Factor Receptor (EGFR) Inhibitor market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The high efficacy of EGFR inhibitors in the treatment of various types of cancer indications has encouraged researchers to study its use in the treatment of inflammatory and monogenic diseases. Recent in-vitro research studies have suggested that EGFR mutations may cause indications such as eczema, psoriasis, and atherosclerosis. Although these studies are in the early stages of clinical trials, the huge unmet need and further advancements in research are expected to brighten the growth prospects of EGFR inhibitors market vendors in new research areas.
Report Covers:
This report presents an overview of global market for Epidermal Growth Factor Receptor (EGFR) Inhibitor market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Epidermal Growth Factor Receptor (EGFR) Inhibitor, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Epidermal Growth Factor Receptor (EGFR) Inhibitor, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Epidermal Growth Factor Receptor (EGFR) Inhibitor revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Epidermal Growth Factor Receptor (EGFR) Inhibitor market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Epidermal Growth Factor Receptor (EGFR) Inhibitor revenue, projected growth trends, production technology, application and end-user industry.
Market Segmentation

Scope of Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Report

Report Metric Details
Report Name Epidermal Growth Factor Receptor (EGFR) Inhibitor Market
Segment by Type
Segment by Application
  • Hospital
  • Research Institutes and Research Institutions
  • Clinic
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Amgen Inc., AstraZeneca Plc, Eli Lilly and Co., F. Hoffmann-La Roche Ltd., Novartis AG
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Revenue of Epidermal Growth Factor Receptor (EGFR) Inhibitor in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Epidermal Growth Factor Receptor (EGFR) Inhibitor companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
  • Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
  • Chapter 8: China by Type, and by Application, revenue for each segment.
  • Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
  • Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
  • Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Epidermal Growth Factor Receptor (EGFR) Inhibitor revenue, gross margin, and recent development, etc.
  • Chapter 12: Analyst's Viewpoints/Conclusions

FAQ for this report

Who are the main players in the Epidermal Growth Factor Receptor (EGFR) Inhibitor Market report?

Ans: The main players in the Epidermal Growth Factor Receptor (EGFR) Inhibitor Market are Amgen Inc., AstraZeneca Plc, Eli Lilly and Co., F. Hoffmann-La Roche Ltd., Novartis AG

What are the Application segmentation covered in the Epidermal Growth Factor Receptor (EGFR) Inhibitor Market report?

Ans: The Applications covered in the Epidermal Growth Factor Receptor (EGFR) Inhibitor Market report are Hospital, Research Institutes and Research Institutions, Clinic, Other

What are the Type segmentation covered in the Epidermal Growth Factor Receptor (EGFR) Inhibitor Market report?

Ans: The Types covered in the Epidermal Growth Factor Receptor (EGFR) Inhibitor Market report are Lung Cancer, Colorectal Cancer, Breast Cancer, Others

Recommended Reports

EGFR & HER2 Markets

Cancer Targeted Therapies

Anti-VEGF/NSCLC Drugs

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Lung Cancer
1.2.3 Colorectal Cancer
1.2.4 Breast Cancer
1.2.5 Others
1.3 Market by Application
1.3.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Hospital
1.3.3 Research Institutes and Research Institutions
1.3.4 Clinic
1.3.5 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Perspective (2019-2030)
2.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Growth Trends by Region
2.2.1 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Historic Market Size by Region (2019-2024)
2.2.3 Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecasted Market Size by Region (2025-2030)
2.3 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Dynamics
2.3.1 Epidermal Growth Factor Receptor (EGFR) Inhibitor Industry Trends
2.3.2 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Drivers
2.3.3 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Challenges
2.3.4 Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Epidermal Growth Factor Receptor (EGFR) Inhibitor by Players
3.1.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue by Players (2019-2024)
3.1.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share by Players (2019-2024)
3.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Epidermal Growth Factor Receptor (EGFR) Inhibitor, Ranking by Revenue, 2022 VS 2023 VS 2024
3.4 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Concentration Ratio
3.4.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue in 2023
3.5 Global Key Players of Epidermal Growth Factor Receptor (EGFR) Inhibitor Head office and Area Served
3.6 Global Key Players of Epidermal Growth Factor Receptor (EGFR) Inhibitor, Product and Application
3.7 Global Key Players of Epidermal Growth Factor Receptor (EGFR) Inhibitor, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Epidermal Growth Factor Receptor (EGFR) Inhibitor Breakdown Data by Type
4.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Historic Market Size by Type (2019-2024)
4.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecasted Market Size by Type (2025-2030)
5 Epidermal Growth Factor Receptor (EGFR) Inhibitor Breakdown Data by Application
5.1 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Historic Market Size by Application (2019-2024)
5.2 Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2019-2030)
6.2 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type
6.2.1 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2019-2024)
6.2.2 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2025-2030)
6.2.3 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Type (2019-2030)
6.3 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application
6.3.1 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2019-2024)
6.3.2 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2025-2030)
6.3.3 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application (2019-2030)
6.4 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country
6.4.1 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country: 2019 VS 2023 VS 2030
6.4.2 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2019-2024)
6.4.3 North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2025-2030)
6.4.4 U.S.
6.4.5 Canada
7 Europe
7.1 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2019-2030)
7.2 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type
7.2.1 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2019-2024)
7.2.2 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2025-2030)
7.2.3 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Type (2019-2030)
7.3 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application
7.3.1 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2019-2024)
7.3.2 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2025-2030)
7.3.3 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application (2019-2030)
7.4 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country
7.4.1 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country: 2019 VS 2023 VS 2030
7.4.2 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2019-2024)
7.4.3 Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2025-2030)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2019-2030)
8.2 China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type
8.2.1 China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2019-2024)
8.2.2 China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2025-2030)
8.2.3 China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Type (2019-2030)
8.3 China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application
8.3.1 China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2019-2024)
8.3.2 China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2025-2030)
8.3.3 China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2019-2030)
9.2 Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type
9.2.1 Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2019-2024)
9.2.2 Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2025-2030)
9.2.3 Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Type (2019-2030)
9.3 Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application
9.3.1 Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2019-2024)
9.3.2 Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2025-2030)
9.3.3 Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application (2019-2030)
9.4 Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Region
9.4.1 Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Region: 2019 VS 2023 VS 2030
9.4.2 Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Region (2019-2024)
9.4.3 Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Region (2025-2030)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (2019-2030)
10.2 Middle East, Africa, and Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type
10.2.1 Middle East, Africa, and Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2019-2024)
10.2.2 Middle East, Africa, and Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2025-2030)
10.2.3 Middle East, Africa, and Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Type (2019-2030)
10.3 Middle East, Africa, and Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application
10.3.1 Middle East, Africa, and Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2019-2024)
10.3.2 Middle East, Africa, and Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2025-2030)
10.3.3 Middle East, Africa, and Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application (2019-2030)
10.4 Middle East, Africa, and Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country
10.4.1 Middle East, Africa, and Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country: 2019 VS 2023 VS 2030
10.4.2 Middle East, Africa, and Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2019-2024)
10.4.3 Middle East, Africa, and Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2025-2030)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Amgen Inc.
11.1.1 Amgen Inc. Company Details
11.1.2 Amgen Inc. Business Overview
11.1.3 Amgen Inc. Epidermal Growth Factor Receptor (EGFR) Inhibitor Introduction
11.1.4 Amgen Inc. Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2019-2024)
11.1.5 Amgen Inc. Recent Developments
11.2 AstraZeneca Plc
11.2.1 AstraZeneca Plc Company Details
11.2.2 AstraZeneca Plc Business Overview
11.2.3 AstraZeneca Plc Epidermal Growth Factor Receptor (EGFR) Inhibitor Introduction
11.2.4 AstraZeneca Plc Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2019-2024)
11.2.5 AstraZeneca Plc Recent Developments
11.3 Eli Lilly and Co.
11.3.1 Eli Lilly and Co. Company Details
11.3.2 Eli Lilly and Co. Business Overview
11.3.3 Eli Lilly and Co. Epidermal Growth Factor Receptor (EGFR) Inhibitor Introduction
11.3.4 Eli Lilly and Co. Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2019-2024)
11.3.5 Eli Lilly and Co. Recent Developments
11.4 F. Hoffmann-La Roche Ltd.
11.4.1 F. Hoffmann-La Roche Ltd. Company Details
11.4.2 F. Hoffmann-La Roche Ltd. Business Overview
11.4.3 F. Hoffmann-La Roche Ltd. Epidermal Growth Factor Receptor (EGFR) Inhibitor Introduction
11.4.4 F. Hoffmann-La Roche Ltd. Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2019-2024)
11.4.5 F. Hoffmann-La Roche Ltd. Recent Developments
11.5 Novartis AG
11.5.1 Novartis AG Company Details
11.5.2 Novartis AG Business Overview
11.5.3 Novartis AG Epidermal Growth Factor Receptor (EGFR) Inhibitor Introduction
11.5.4 Novartis AG Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2019-2024)
11.5.5 Novartis AG Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
FEATURED COMPANIES
Amgen Inc
Astrazeneca plc
Eli Lilly and Co
F Hoffmann La Roche Ltd
Novartis
List of Tables
    Table 1. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Lung Cancer
    Table 3. Key Players of Colorectal Cancer
    Table 4. Key Players of Breast Cancer
    Table 5. Key Players of Others
    Table 6. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 7. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 8. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Region (2019-2024) & (US$ Million)
    Table 9. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Region (2019-2024)
    Table 10. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 11. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Region (2025-2030)
    Table 12. Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Trends
    Table 13. Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Drivers
    Table 14. Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Challenges
    Table 15. Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Restraints
    Table 16. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue by Players (2019-2024) & (US$ Million)
    Table 17. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Share by Players (2019-2024)
    Table 18. Global Top Epidermal Growth Factor Receptor (EGFR) Inhibitor by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor as of 2023)
    Table 19. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Industry Ranking 2022 VS 2023 VS 2024
    Table 20. Global 5 Largest Players Market Share by Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue (CR5 and HHI) & (2019-2024)
    Table 21. Global Key Players of Epidermal Growth Factor Receptor (EGFR) Inhibitor, Headquarters and Area Served
    Table 22. Global Key Players of Epidermal Growth Factor Receptor (EGFR) Inhibitor, Product and Application
    Table 23. Global Key Players of Epidermal Growth Factor Receptor (EGFR) Inhibitor, Product and Application
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2019-2024) & (US$ Million)
    Table 26. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share by Type (2019-2024)
    Table 27. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 28. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Market Share by Type (2025-2030)
    Table 29. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2019-2024) & (US$ Million)
    Table 30. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Share by Application (2019-2024)
    Table 31. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 32. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue Share by Application (2025-2030)
    Table 33. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2019-2024) & (US$ Million)
    Table 34. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2025-2030) & (US$ Million)
    Table 35. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2019-2024) & (US$ Million)
    Table 36. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2025-2030) & (US$ Million)
    Table 37. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 38. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2019-2024) & (US$ Million)
    Table 39. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2025-2030) & (US$ Million)
    Table 40. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2019-2024) & (US$ Million)
    Table 41. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2025-2030) & (US$ Million)
    Table 42. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2019-2024) & (US$ Million)
    Table 43. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2025-2030) & (US$ Million)
    Table 44. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 45. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2019-2024) & (US$ Million)
    Table 46. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2025-2030) & (US$ Million)
    Table 47. China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2019-2024) & (US$ Million)
    Table 48. China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2025-2030) & (US$ Million)
    Table 49. China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2019-2024) & (US$ Million)
    Table 50. China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2025-2030) & (US$ Million)
    Table 51. Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2019-2024) & (US$ Million)
    Table 52. Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2025-2030) & (US$ Million)
    Table 53. Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2019-2024) & (US$ Million)
    Table 54. Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2025-2030) & (US$ Million)
    Table 55. Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 56. Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Region (2019-2024) & (US$ Million)
    Table 57. Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Region (2025-2030) & (US$ Million)
    Table 58. Middle East, Africa, and Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2019-2024) & (US$ Million)
    Table 59. Middle East, Africa, and Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Type (2025-2030) & (US$ Million)
    Table 60. Middle East, Africa, and Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2019-2024) & (US$ Million)
    Table 61. Middle East, Africa, and Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Application (2025-2030) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 63. Middle East, Africa, and Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2019-2024) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size by Country (2025-2030) & (US$ Million)
    Table 65. Amgen Inc. Company Details
    Table 66. Amgen Inc. Business Overview
    Table 67. Amgen Inc. Epidermal Growth Factor Receptor (EGFR) Inhibitor Product
    Table 68. Amgen Inc. Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2019-2024) & (US$ Million)
    Table 69. Amgen Inc. Recent Developments
    Table 70. AstraZeneca Plc Company Details
    Table 71. AstraZeneca Plc Business Overview
    Table 72. AstraZeneca Plc Epidermal Growth Factor Receptor (EGFR) Inhibitor Product
    Table 73. AstraZeneca Plc Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2019-2024) & (US$ Million)
    Table 74. AstraZeneca Plc Recent Developments
    Table 75. Eli Lilly and Co. Company Details
    Table 76. Eli Lilly and Co. Business Overview
    Table 77. Eli Lilly and Co. Epidermal Growth Factor Receptor (EGFR) Inhibitor Product
    Table 78. Eli Lilly and Co. Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2019-2024) & (US$ Million)
    Table 79. Eli Lilly and Co. Recent Developments
    Table 80. F. Hoffmann-La Roche Ltd. Company Details
    Table 81. F. Hoffmann-La Roche Ltd. Business Overview
    Table 82. F. Hoffmann-La Roche Ltd. Epidermal Growth Factor Receptor (EGFR) Inhibitor Product
    Table 83. F. Hoffmann-La Roche Ltd. Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2019-2024) & (US$ Million)
    Table 84. F. Hoffmann-La Roche Ltd. Recent Developments
    Table 85. Novartis AG Company Details
    Table 86. Novartis AG Business Overview
    Table 87. Novartis AG Epidermal Growth Factor Receptor (EGFR) Inhibitor Product
    Table 88. Novartis AG Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2019-2024) & (US$ Million)
    Table 89. Novartis AG Recent Developments
    Table 90. Research Programs/Design for This Report
    Table 91. Key Data Information from Secondary Sources
    Table 92. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Type: 2023 VS 2030
    Figure 3. Lung Cancer Features
    Figure 4. Colorectal Cancer Features
    Figure 5. Breast Cancer Features
    Figure 6. Others Features
    Figure 7. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 8. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application: 2023 VS 2030
    Figure 9. Hospital Case Studies
    Figure 10. Research Institutes and Research Institutions Case Studies
    Figure 11. Clinic Case Studies
    Figure 12. Other Case Studies
    Figure 13. Epidermal Growth Factor Receptor (EGFR) Inhibitor Report Years Considered
    Figure 14. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 15. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 16. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Region: 2023 VS 2030
    Figure 17. Global Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Players in 2023
    Figure 18. Global Top Epidermal Growth Factor Receptor (EGFR) Inhibitor Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Epidermal Growth Factor Receptor (EGFR) Inhibitor as of 2023)
    Figure 19. The Top 10 and 5 Players Market Share by Epidermal Growth Factor Receptor (EGFR) Inhibitor Revenue in 2023
    Figure 20. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Type (2019-2030)
    Figure 22. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application (2019-2030)
    Figure 23. North America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Country (2019-2030)
    Figure 24. United States Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. Canada Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY (2019-2030) & (US$ Million)
    Figure 27. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Type (2019-2030)
    Figure 28. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application (2019-2030)
    Figure 29. Europe Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Country (2019-2030)
    Figure 30. Germany Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. France Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 32. U.K. Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Italy Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. Russia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Nordic Countries Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY (2019-2030) & (US$ Million)
    Figure 37. China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Type (2019-2030)
    Figure 38. China Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application (2019-2030)
    Figure 39. Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY (2019-2030) & (US$ Million)
    Figure 40. Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Type (2019-2030)
    Figure 41. Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application (2019-2030)
    Figure 42. Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Region (2019-2030)
    Figure 43. Japan Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 44. South Korea Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. China Taiwan Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Southeast Asia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. India Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. Australia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Middle East, Africa, and Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY (2019-2030) & (US$ Million)
    Figure 50. Middle East, Africa, and Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Type (2019-2030)
    Figure 51. Middle East, Africa, and Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Application (2019-2030)
    Figure 52. Middle East, Africa, and Latin America Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Share by Country (2019-2030)
    Figure 53. Brazil Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 54. Mexico Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 55. Turkey Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 56. Saudi Arabia Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Israel Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. GCC Countries Epidermal Growth Factor Receptor (EGFR) Inhibitor Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. Amgen Inc. Revenue Growth Rate in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2019-2024)
    Figure 60. AstraZeneca Plc Revenue Growth Rate in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2019-2024)
    Figure 61. Eli Lilly and Co. Revenue Growth Rate in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2019-2024)
    Figure 62. F. Hoffmann-La Roche Ltd. Revenue Growth Rate in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2019-2024)
    Figure 63. Novartis AG Revenue Growth Rate in Epidermal Growth Factor Receptor (EGFR) Inhibitor Business (2019-2024)
    Figure 64. Bottom-up and Top-down Approaches for This Report
    Figure 65. Data Triangulation
    Figure 66. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Accenture

SIMILAR REPORTS

Global Epidermal Growth Factor Receptor Inhibitors Market Research Report 2024
Global HER2 Target Drugs Market Research Report 2024
Global HER2 Human Epidermal Growth Factor Receptor 2 Antibody Market Research Report 2024
Global Human EGFR Gene Mutation Detection Kit Market Research Report 2024
Global HER2 Human Epidermal Growth Factor Receptor 2 Inhibitors Market Research Report 2024
Global HER2 Positive Breast Cancer Market Research Report 2024
Global Cetuximab Market Insights Forecast to 2030
Global Epidermal Growth Factor EGF Antibody Market Research Report 2024
Global Anti aging EGF Market Research Report 2025
Global EGFR TKI Market Research Report 2024
Global Cosmetic Grade EGF Market Research Report 2025
Global Mouse EGF Protein Market Research Report 2025
Global Recombinant Mouse EGF Protein Market Research Report 2025
Global Receptor Tyrosine protein Kinase ERBB 3 Antibody Market Research Report 2024
Global Epidermal Growth Factor Receptor EGFR ELISA Kit Market Research Report 2024
Global Recombinant Human EGF Market Insights Forecast to 2030
Global Epidermal Growth Factor Market Research Report 2024
Global HER2 Antibody Market Research Report 2025
Global Tyrosine Kinase Inhibitors Market Research Report 2024
Global Anti HER2 Therapy Market Research Report 2025
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions